Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112811996B details a metal-free catalytic method for synthesizing chiral ketones with high enantioselectivity, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN101054351B enables solvent-free phenylcarbamate production. Reduces energy consumption and simplifies separation for reliable supply chain partners.
Patent CN104892496A details a Rhodium-catalyzed asymmetric hydrogenation method offering high ee values and scalable production for pharmaceutical intermediates.
Patent CN104892377B reveals zinc-catalyzed alkyne oxidation for high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability for global buyers.
Patent CN117430539A reveals catalyst-free lactam synthesis. Achieve cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable processes.
Patent CN121426651A reveals TEMPO-catalyzed oxidation. Offers cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Patent CN115260205A reveals novel bispyrene-doped extended porphyrins with high asymmetry factors. Discover cost-effective synthesis for OLED and chiral catalysis applications.
Advanced anhydrous synthesis of bis(2-dimethylaminoethyl) ether via patent CN102786427B. Delivers >99% purity for polyurethane catalysts with reduced solvent waste.
Novel biomimetic catalytic transfer hydrogenation for aprepitant intermediates. High yield, mild conditions, cost-effective manufacturing solution.
Patent CN107400044B discloses a Ru-catalyzed hydrogenation method for alpha,alpha-difluoroacetates, offering a scalable alternative to hydride reduction for pharmaceutical intermediates.
Patent CN117358313B reveals manganese catalysis for indole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103613628B reveals a green catalytic hydrogenation route for 25-hydroxycholesterol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Novel dual-catalyst method reduces genotoxic impurities in nifedipine intermediates, offering cost-effective scale-up for API manufacturers.
Novel Grignard-based synthesis omits hydrolysis steps, enhancing yield and supply chain reliability for high-purity quaternary phosphonium salt manufacturing.
Patent CN111825508A details asymmetric hydrogenation for high-purity chiral amines, offering cost-effective pharma intermediate manufacturing solutions.
Patent CN1466487A details a safe nickel-catalyzed cross-coupling process eliminating cryogenic conditions, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN1179933C reveals novel electron donors for olefin polymerization. Enhances stereospecificity and offers scalable manufacturing solutions for industrial catalysts.
Patent CN109970560B details a green calcium-catalyzed route for 1,3-dienes, offering cost reduction in API manufacturing and high-purity intermediates.
Patent CN116396196B reveals a catalyst-free one-pot method for amidoisothiocyanate synthesis. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112110817B details a high-efficiency pyridine-palladium catalyzed carbonylation for diaryl esters. Discover cost-effective, green manufacturing solutions.